Dental Plaque Clinical Trial
Official title:
Evaluation of the Efficacy of a Commercially Available Regimen Versus Brushing Alone on Established Plaque and Gingivitis on Adolescents: Study Protocol for a Randomized, Controlled, Blind Clinical Trial
Verified date | September 2020 |
Source | University of Nove de Julho |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate: 1) Evaluate the efficacy of a regimen commercially available versus brush alone on established plaque and gingivitis on adolescents. The Group 1 will use the following procedure: Colgate Ultrasoft toothbrush, Colgate Total 12 toothpaste and Plax Mouthwash, and the other Group will use Colgate Ultrasoft toothbrush and Colgate Cavity Protection toothpaste; 2) The level of halitosis. Two calibrated and blinded examiners (Cohen Kappa 85%) will evaluate the gingival condition using the visible plaque indices, a simplified oral hygiene index - IHOS and gingival bleeding index, with the aid of a WHO probe. For the evaluation of halitosis levels, all individuals will respond to a questionnaire regarding personal data, general and oral health, which includes hygiene habits and received previous guidelines for the procedures to be performed in the second moment. At the next consultation, subjects will be assessed clinically for halitosis using the portable BreathAlert™ sulfide monitor (Tanita Corporation, Japan), in addition to the evaluation of the tongue flap index (ISL), pH and salivary flow. The evaluations will be in the following periods: baseline, 1, 3 and 6 months of brushing. Data will be submitted to descriptive statistical analysis to demonstrate the distributions frequency of biofilm indices and gingival bleeding. The differences in the criteria evaluated will be submitted to Fisher's exact test (α = 0.05) and their performance at different times will be evaluated by the Mann-Whitney test (α = 0.05).
Status | Not yet recruiting |
Enrollment | 58 |
Est. completion date | December 25, 2021 |
Est. primary completion date | June 30, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Good general health; - Age 12 to 17; - Absence of motor, comprehension and cognitive difficulties that impede adequate oral hygiene. Exclusion Criteria: - Active dental caries with cavity exposing dentin (visible cavity) on teeth for which the simplified oral hygiene index will be used. If these teeth are not present, adjacent teeth may be considered; - Teeth with formation defects and dental crowding; - Periodontal disease (tooth mobility > 2 mm, pocket > 5 mm, gingivitis); - Parafunctional habits (bruxism, nail biting), active clamps for removable partial dentures, use of orthodontic appliance; - Volunteer or legal guardian who does not agree with the terms of the study or has difficulty appearing for the follow up appointments; - Pregnant volunteers; - Use of medications that alter gingival health, such as antibiotics, in the previous three months; - Use of mouthwash or toothpaste containing products for the control of biofilm; - Smokers; - Systemic disease (diabetes). |
Country | Name | City | State |
---|---|---|---|
Brazil | Universidade Metropolitana de Santos | Santos | SP |
Lead Sponsor | Collaborator |
---|---|
University of Nove de Julho |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of change in biofilm index | The gingival health assessments will be performed through a visual examination for the determination of the visible plaque index, gingival bleeding and oral health at baseline as well as after the use of brush. | Baseline, after 1, 3 and 6 months of toothbrushing. | |
Secondary | Change in halitosis index | Halitosis index using the portable BreathAlert™ sulfide monitor (Tanita Corporation, Japan). | Baseline, after 1, 3 and 6 months of toothbrushing. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04881357 -
Antiplaque/Antigingivitis Effect of Lacer Oros Integral
|
N/A | |
Completed |
NCT04561960 -
Efficacy of Miswak in Oral Hygiene Maintenance
|
Phase 4 | |
Completed |
NCT04025684 -
Efficacy of Manual Toothbrushes in Removing Dental Plaque
|
N/A | |
Completed |
NCT03394729 -
Effect of a Propolis Tablet on the Saliva and the Amount of Adolescent Dental Plaque Microbes
|
Phase 2/Phase 3 | |
Completed |
NCT05187507 -
Effectiveness of Theobromine Toothpaste
|
N/A | |
Completed |
NCT04485520 -
Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans
|
N/A | |
Completed |
NCT02552589 -
Effect of Toothpaste on the Reduction of Plaque and Inflammation
|
N/A | |
Completed |
NCT02884817 -
Essential Oil+ELA, Plaque and Gingivitis
|
Phase 4 | |
Completed |
NCT02194023 -
Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.
|
Phase 2 | |
Completed |
NCT01237782 -
Efficacy of a Propolis-based Denture Cleanser
|
N/A | |
Completed |
NCT00758394 -
Clinical Study to Compare Dental Plaque Control
|
Phase 3 | |
Completed |
NCT00254345 -
Effect of Provisional-Crown Surface Coating on Biofilm Formation
|
Phase 1 | |
Completed |
NCT05579938 -
Effect of Enzymes on Dental Biofilm Accumulation
|
N/A | |
Completed |
NCT05038293 -
Efficacy of Plaque Removal of a Novel Brushing Device
|
N/A | |
Terminated |
NCT05082103 -
Effect of Enzymes on Dental Biofilm Accumulation in Healthy Individuals
|
N/A | |
Not yet recruiting |
NCT06081868 -
RCT on Effectiveness of Oral Health Preventive Programmes in School Children in Uganda
|
N/A | |
Completed |
NCT05853679 -
Regular Antibacterial Photodynamic Therapy on Oral Hygiene in Elderly Residents
|
N/A | |
Completed |
NCT05521230 -
Short-Term Anti-plaque Effect of Cymenol Mouthwash Analysed Using Dentius Deep Plaque Software
|
Phase 1 | |
Completed |
NCT03311438 -
Oral Health Intervention Program for Children With Congenital Heart Defects
|
N/A | |
Enrolling by invitation |
NCT06122636 -
Efficacy of a Probiotic and Microbiological Analysis on Oral Complications Induced by Antineoplastic Therapies in Patients With HNC
|
N/A |